michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
Published 4 years ago • 77 plays • Length 2:01
Download video MP4
Download video MP3
Similar videos
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:01
rana mckay, md, discusses checkmate214 investigating nivolumab ipilimumab in 1st line rcc patients
-
0:44
michael atkins, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
-
0:58
michael atkins, md, regarding the keynote 426 phase iii trial in metastatic renal cell carcinoma
-
0:51
michael atkins, md, shares exciting potential of current late-stage clinical studies in rcc patients
-
0:55
michael atkins, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
1:37
michael b. atkins, md, comments on clinical trials investigating the use of i-o and tkis in rcc
-
0:40
michael atkins, md, considers how to treat mrcc after combination i-o in the 1st line setting
-
1:20
michael atkins, md, offers opinion on io-tki combinations in renal cell cancer
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
8:32
dr. michael b. atkins on treating advanced kidney cancer
-
2:53
michael b. atkins, md, regarding the long-term follow up of checkmate-004 in metastatic melanoma
-
3:07
checkmate-214: nivolumab/ipilimumab for mrcc?
-
2:35
dr. atkins on long-term survival benefit of nivolumab/ipilimumab in advanced melanoma
-
0:41
michael atkins, md, on appropriate patient types to receive a tki in the treatment of 1st line rcc
-
1:26
atkins: pembrolizumab, ipilimumab for melanoma, rcc
-
5:06
phase 3 checkmate - 214
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:24
dr. atkins on adjuvant ipilimumab in melanoma
Clip.africa.com - Privacy-policy